INSPARIN Therpeutics stands at the forefront of a new era in glucose management, offering innovative insulin-independent treatment options for patients with severe insulin resistance syndromes, rare genetic insulin receptor deficiencies, lipodystrophies and other metabolic diseases that affect mostly children and adolescents.
Company Details
- Employees
- 1
- Address
- Liberty Science Center
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://insparin.com
- Keywords
- Kathera Bioscience Inc..
Insparin Therapeutics Questions
Insparin Therapeutics's website is https://insparin.com
Insparin Therapeutics's LinkedIn profile is https://www.linkedin.com/company/insparin
Insparin Therapeutics has
1 employees.
View email and phone details for 1
employees at Insparin Therapeutics.
Insparin Therapeutics's industry is
Biotechnology Research
Insparin Therapeutics's top competitors are
Biotechexec,
Kathera Bioscience Inc.,
Nextcure, Inc.,
Immunophotonics, Inc.,
Workshare,
Ollen Group,
Vaxine Pty Ltd,
Trialsite News,
Crosstx,
The Athlete Content Company.
Insparin Therapeutics's categories are Biotechnology Research
